About the project
FLAVIVACCINE develops a novel mosquito saliva-targeted vaccine candidate that protects against different flaviviruses and is ready for clinical evaluation by building upon an experimentally validated proof-of-concept.
The pan-flavivirus will have short- and long-term impact on the EU ability to combat epidemic and pandemic viral threats, and protect communities and citizens in the EU and around the world.
